Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Kyowa Kirin Ltd, Galabank Business Park, Galashiels, TD1 1QH, United Kingdom, Tel. +44 (0)1896 664000
Xomolix 2.5 mg/ml solution for injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. Clear colourless solution, free from visible particles. The pH of droperidol solution for injection is 3.0-3.8 and has an osmolarity of approximately 300 milliosmol/kg water. |
Each millilitre of the solution contains 2.5 mg droperidol.
Excipient: sodium <23 mg per ml (see section 4.4 for further details).
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Droperidol |
Droperidol is a butyrophenone neuroleptic. Its pharmacologic profile is characterised mainly by dopamine-blocking and weak α1-adrenolytic effects. Droperidol is devoid of anticholinergic and antihistaminic activity. |
| List of Excipients |
|---|
|
Mannitol |
Type I amber glass ampoules containing 1 ml solution for injection, in packs of 10 ampoules.
Kyowa Kirin Ltd, Galabank Business Park, Galashiels, TD1 1QH, United Kingdom, Tel. +44 (0)1896 664000
PL 16508/0036
28.01.2008
| Drug | Countries | |
|---|---|---|
| XOMOLIX | Austria, Spain, Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
